Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue $ 349,257 $ 740,600
Costs and expenses:    
Cost of products and services 233,310 358,628
Research and development 272,023 435,646
Selling and marketing 130,173 226,015
General and administrative 1,198,309 3,358,056
Total operating costs 1,833,815 4,378,345
Operating loss (1,484,558) (3,637,745)
Other (expense) income:    
Interest expense, net (5,384,991) (3,893,686)
Unrealized gain on investment in equity securities 4,155 8,061
Gain (loss) on extinguishment of liabilities (1,211,511) 659,277
Other income (expense) 2,482 6,259
Total other expense (6,589,865) (3,220,089)
Net loss (8,074,423) (6,857,834)
Preferred stock dividends (632,053) (431,807)
Net loss attributable to common shareholders $ (8,706,476) $ (7,289,641)
Basic net loss per share attributable to common shareholders $ (0.22) $ (0.46)
Diluted net loss per share attributable to common shareholders $ (0.22) $ (0.46)
Weighted average common shares outstanding used in the basic net loss per share calculation 39,811,524 15,839,373
Weighted average common shares outstanding used in the diluted net loss per share calculation 39,811,524 15,839,373
Products Services Other [Member]    
Revenue:    
Total revenue $ 349,257 $ 740,600